Human Anti-HIV-1 Env Recombinant Antibody (clone N3C5) (CAT#: MRO-2810CQ)

Recombinant Humanized Antibody to Env. N3C5 was shown to bind to both homologous gp140 and heterologous gp140 from clades C and A with high affinity, but not to clade B. It was shown to bind conformational epitope within the immunodominant region of gp41


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Binding of monomeric and pentameric forms of N3C5 and N03B11 to gp14097CN54.

Figure 1 Binding of monomeric and pentameric forms of N3C5 and N03B11 to gp14097CN54.

Pooled fractions from the 900- and 180-kDa fractions after liquid chromatography were tested by ELISA at 0.05 μg/ ml (N3C5) and 1 μg/ml (N03B11).

Sheppard, N. C., Davies, S. L., Jeffs, S. A., Vieira, S. M., & Sattentau, Q. J. (2007). Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins. Clin. Vaccine Immunol., 14(2), 157-167.

ELISA

Figure 2 Defining the epitopes of MAbs N3C5 and N03B11.

Figure 2 Defining the epitopes of MAbs N3C5 and N03B11.

Binding of MAbs N3C5 and N03B11 to native and denatured gp14097CN54. Squares represent N3C5 and triangles represent N03B11.

Sheppard, N. C., Davies, S. L., Jeffs, S. A., Vieira, S. M., & Sattentau, Q. J. (2007). Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins. Clin. Vaccine Immunol., 14(2), 157-167.

Inhib

Figure 3 Defining the epitopes of MAbs N3C5 and N03B11.

Figure 3 Defining the epitopes of MAbs N3C5 and N03B11.

Reciprocal MAb competition studies by SPR and ELISA.

Sheppard, N. C., Davies, S. L., Jeffs, S. A., Vieira, S. M., & Sattentau, Q. J. (2007). Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins. Clin. Vaccine Immunol., 14(2), 157-167.

Neu

Figure 4 The neutralization of HIV-197CN54 by IgM MAbs N3C5 and N03B11.

Figure 4 The neutralization of HIV-197CN54 by IgM MAbs N3C5 and N03B11.

Bars represent percent neutralization compared to an equal concentration of an irrelevant Ab (D7324). The MAbs were also combined with heat-inactivated (HI) or fresh (C) serum (NHS) to assess CMI. N3C5 and N03B11 were used at 100 μg/ml while the positive control, MAb 447-52D, was used at 10 μg/ml 1.

Sheppard, N. C., Davies, S. L., Jeffs, S. A., Vieira, S. M., & Sattentau, Q. J. (2007). Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressingontrol, MAb 447-52D, was used at 10 μg/ml 1.


Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized IgM
  • Specificity
  • Recognizes HIV-1 Env
  • Species Reactivity
  • HIV-1
  • Clone
  • N3C5
  • Applications
  • ELISA, Inhib

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The HIV-1 Env antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Inhibition.
    ELISA: 0.05 μg/ml.

Target

  • Alternative Names
  • ENV; gp160; envelope glycoprotein; Envelope surface glycoprotein gp160; precursor; hypothetical protein; Envelope surface glycoprotein gp120; Envelope transmembrane domain

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone N3C5"

See other products for "HIV-1 Env"

Single-domain Antibody

CAT Product Name Application Type
NABG-057 Recombinant Anti-HIV-1 env VHH Single Domain Antibody ELISA, IHC, FC, FuncS Llama VHH

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-2810CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare